Modeling tumor immunity of mouse glioblastoma by exhausted CD8+ T cells-Reference-Cited by-同舟云学术

Modeling tumor immunity of mouse glioblastoma by exhausted CD8+ T cells

Published:2018-01-09 Issue:1 Volume:8 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Nakashima Hiroshi,Alayo Quazim A.,Penaloza-MacMaster Pablo,Freeman Gordon J.,Kuchroo Vijay K.,Reardon David A.,Fernandez Soledad,Caligiuri Michael,Chiocca E. Antonio

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-017-18540-2.pdf

Reference58 articles.

1. Brennan, C. W. et al. The somatic genomic landscape of glioblastoma. Cell 155, 462–477, https://doi.org/10.1016/j.cell.2013.09.034 (2013).

2. Barber, D. L. et al. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439, 682–687, https://doi.org/10.1038/nature04444 (2006).

3. Speiser, D. E. et al. T cell differentiation in chronic infection and cancer: functional adaptation or exhaustion? Nat Rev Immunol 14, 768–774, https://doi.org/10.1038/nri3740 (2014).

4. Pauken, K. E. & Wherry, E. J. Overcoming T cell exhaustion in infection and cancer. Trends Immunol 36, 265–276, https://doi.org/10.1016/j.it.2015.02.008 (2015).

5. Wherry, E. J. & Kurachi, M. Molecular and cellular insights into T cell exhaustion. Nat Rev Immunol 15, 486–499, https://doi.org/10.1038/nri3862 (2015).

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. KR158 Spheres Harboring Slow-Cycling Cells Recapitulate High-Grade Glioma Features in an Immunocompetent System;Cells;2024-05-29

2. KR158 spheres harboring slow-cycling cells recapitulate GBM features in an immunocompetent system;2024-01-30

3. Triggering receptor expressed on myeloid cells 2 (TREM2) regulates phagocytosis in glioblastoma;Neuro-Oncology;2024-01-18

4. Biomaterial-based in vitro 3D modeling of glioblastoma multiforme;Cancer Pathogenesis and Therapy;2023-07

5. Translational Models in Glioma Immunotherapy Research;Current Oncology;2023-06-11